Recent studies have reported that mitochondrial metabolism regulated by mTOR limits mycobacteria-induced cytotoxicity (Pagán et al., 2022) suggesting that screening new anti-TB drugs from existing drugs that target mTOR may be a good direction. This evidence concerns the gene MTOR and tuberculosis.